Predicting Stroke for Pediatric Patients Supported With Ventricular Assist Devices: A Pedimacs Report

Awais Ashfaq1, Angela Lorts1, David Rosenthal2

  • 1Division of Cardiovascular Surgery, Department of Surgery, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

PubMed

Insights

Stroke risk in pediatric ventricular assist device (VAD) patients has decreased, especially with paracorporeal pulsatile devices. Risk factor analysis helps refine management for better outcomes in VAD therapy.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Neurology

Background:

  • The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) database offers insights into pediatric patients requiring ventricular assist devices (VADs).
  • Stroke is a significant complication in pediatric VAD recipients, necessitating identification of risk factors and trends.

Purpose of the Study:

  • To analyze stroke incidence in pediatric patients receiving VADs using Pedimacs data.
  • To identify key variables influencing stroke risk in this population.

Main Methods:

  • Utilized multiphase parametric hazard modeling on data from 1219 pediatric patients (aged <19) implanted with 1463 VADs between 2012 and 2022.
  • Analyzed stroke risk factors across different VAD types and patient demographics.

Main Results:

  • Overall freedom from stroke at 6 months improved from 80.2% (2012-2016) to 87.9% (2017-2023).
  • Implantable continuous VADs showed the highest stroke-free rates (91.1% at 6 months).
  • Early stroke risk decreased significantly in the recent era (hazard ratio, 5.01), particularly for paracorporeal pulsatile devices.

Conclusions:

  • The overall stroke rate in pediatric VAD patients has decreased, with notable improvements in paracorporeal pulsatile device recipients.
  • Risk factor analysis provides crucial information for identifying high-risk patients and optimizing VAD management strategies.
Abstract